Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
NTRA

NTRA - Natera Inc Stock Price, Fair Value and News

106.41USD-2.09 (-1.93%)Market Closed

Market Summary

NTRA
USD106.41-2.09
Market Closed
-1.93%

NTRA Alerts

  • 5 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

NTRA Stock Price

View Fullscreen

NTRA RSI Chart

NTRA Valuation

Market Cap

13.1B

Price/Earnings (Trailing)

-35.76

Price/Sales (Trailing)

10.81

EV/EBITDA

-37.35

Price/Free Cashflow

-69.89

NTRA Price/Sales (Trailing)

NTRA Profitability

EBT Margin

-30.19%

Return on Equity

-46.02%

Return on Assets

-24.89%

Free Cashflow Yield

-1.43%

NTRA Fundamentals

NTRA Revenue

Revenue (TTM)

1.2B

Rev. Growth (Yr)

52.11%

Rev. Growth (Qtr)

18.2%

NTRA Earnings

Earnings (TTM)

-365.5M

Earnings Growth (Yr)

50.63%

Earnings Growth (Qtr)

13.37%

Breaking Down NTRA Revenue

Last 7 days

1.1%

Last 30 days

17.8%

Last 90 days

52.0%

Trailing 12 Months

114.4%

How does NTRA drawdown profile look like?

NTRA Financial Health

Current Ratio

4.12

NTRA Investor Care

Shares Dilution (1Y)

7.44%

Diluted EPS (TTM)

-3.12

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.2B000
2023867.8M931.0M988.7M1.1B
2022667.3M723.5M776.0M820.2M
2021449.3M504.9M564.8M625.5M
2020329.5M341.6M361.9M391.0M
2019262.1M273.4M286.1M302.3M
2018222.6M233.4M242.7M257.7M
2017204.6M204.9M206.9M209.6M
2016204.8M211.7M220.7M217.1M
2015179.4M188.7M187.3M190.4M
201481.2M107.2M133.3M159.3M
201300055.2M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Natera Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 10, 2024
rabinowitz daniel
sold
-3,137,570
104
-30,000
sec. and chief legal officer
May 10, 2024
sheena jonathan
sold
-283,794
105
-2,700
-
May 10, 2024
rabinowitz daniel
acquired
590,400
19.68
30,000
sec. and chief legal officer
May 08, 2024
rabinowitz matthew
acquired
1,159,990
5.3953
215,000
executive chairman
May 01, 2024
brophy michael burkes
sold
-175,344
93.9676
-1,866
chief financial officer
Apr 29, 2024
brophy michael burkes
sold
-115,306
93.1387
-1,238
chief financial officer
Apr 29, 2024
chapman steven leonard
sold
-380,378
93.1387
-4,084
ceo and president
Apr 29, 2024
moshkevich solomon
sold
-111,394
93.1387
-1,196
president, clinicaldiagnostics
Apr 29, 2024
fesko john
sold
-86,525
93.1387
-929
president, chief bus. officer

1–10 of 50

Which funds bought or sold NTRA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
Virtus Investment Advisers, Inc.
unchanged
-
102,772
326,146
0.23%
May 16, 2024
CASTLEARK MANAGEMENT LLC
new
-
6,825,660
6,825,660
0.28%
May 16, 2024
COMERICA BANK
sold off
-100
-1,710
-
-%
May 16, 2024
JANE STREET GROUP, LLC
sold off
-100
-103,024
-
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-3.94
2,985,520
10,401,500
0.01%
May 16, 2024
COMERICA BANK
added
458
1,192,850
1,359,720
0.01%
May 16, 2024
JANE STREET GROUP, LLC
added
61.75
6,145,540
10,658,600
-%
May 15, 2024
BRANDYWINE MANAGERS, LLC
unchanged
-
502,736
1,595,430
1.57%
May 15, 2024
SILVERCREST ASSET MANAGEMENT GROUP LLC
reduced
-39.08
-1,075,370
8,655,320
0.06%
May 15, 2024
PERCEPTIVE ADVISORS LLC
reduced
-10.94
15,997,700
69,255,800
1.20%

1–10 of 36

Are Funds Buying or Selling NTRA?

Are funds buying NTRA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NTRA
No. of Funds

Unveiling Natera Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
alger associates inc
5.9%
7,076,157
SC 13G/A
Feb 13, 2024
vanguard group inc
9.13%
10,971,895
SC 13G/A
Jan 31, 2024
blackrock inc.
5.2%
6,305,838
SC 13G
Jan 23, 2024
jpmorgan chase & co
6.6%
7,964,473
SC 13G/A
Apr 06, 2023
blackrock inc.
4.9%
5,509,188
SC 13G/A
Feb 14, 2023
alger associates inc
8.2%
8,972,721
SC 13G/A
Feb 09, 2023
vanguard group inc
9.01%
9,945,514
SC 13G/A
Feb 03, 2023
blackrock inc.
5.1%
5,566,743
SC 13G
Jan 23, 2023
jpmorgan chase & co
5.6%
6,211,632
SC 13G/A
Jun 09, 2022
blackrock inc.
4.9%
4,706,415
SC 13G

Recent SEC filings of Natera Inc

View All Filings
Date Filed Form Type Document
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 15, 2024
144
Notice of Insider Sale Intent
May 10, 2024
10-Q
Quarterly Report
May 10, 2024
144
Notice of Insider Sale Intent
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 09, 2024
8-K
Current Report
May 03, 2024
4
Insider Trading

Peers (Alternatives to Natera Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
196.9B
23.7B
11.04% 17.40%
44.73
8.29
-8.94% -35.91%
45.2B
6.7B
14.64% 19.44%
36.57
6.71
-2.81% -6.58%
44.9B
3.7B
13.71% 10.52%
51.83
12.06
8.57% 23.94%
16.0B
9.3B
13.66% 10.24%
18.95
1.73
-3.29% 6.68%
13.1B
1.2B
17.80% 114.36%
-35.76
10.81
39.26% 33.08%
12.2B
2.0B
2.71% 87.82%
38.94
6.2
25.57% 21.62%
11.4B
4.1B
-3.66% 11.24%
26.02
2.78
0.49% -11.59%
9.3B
2.5B
-20.33% -38.03%
-38.69
3.67
15.21% 53.51%
MID-CAP
3.1B
603.7M
54.73% -14.09%
-6.73
5.14
25.21% 30.68%
2.9B
929.2M
11.70% -18.80%
1.9K
3.16
28.93% 111.61%
SMALL-CAP
808.3M
275.1M
87.44% 103.94%
-4.41
2.94
-13.93% -126.97%
84.8M
31.1M
-3.25% -85.34%
-1.1
2.73
0.95% 19.75%
33.0M
9.2M
-24.07% -37.65%
-2.24
3.6
11.85% 45.80%
2.5M
5.5M
-62.31% 120.18%
-0.2
0.45
-68.52% -141.15%
183.8K
25.9M
-50.00% -94.83%
-0.01
0.01
-57.78% -93.11%

Natera Inc News

Latest updates
Yahoo Canada Finance14 hours ago
Defense World16 May 202411:00 am
Nasdaq08 May 202402:39 pm

Natera Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue18.2%367,741,000311,105,000268,306,000261,404,000241,756,000217,252,000210,637,000198,200,000194,133,000173,028,000158,116,000142,026,000152,316,000112,378,00098,143,00086,472,00094,012,00083,240,00077,909,00074,355,00066,824,000
Costs and Expenses11.7%442,055,000395,641,000379,288,000373,830,000380,057,000359,025,000329,689,000341,285,000331,263,000312,694,000308,313,000257,320,000215,333,000186,346,000153,920,000138,132,000128,884,000118,051,00099,003,000102,991,00098,570,000
  S&GA Expenses20.3%194,278,000161,430,000154,742,000152,508,000149,627,000143,822,000147,667,000149,468,000147,634,000146,761,000128,485,000127,456,000108,332,00094,080,00075,678,00068,188,00065,681,00058,587,00056,715,00047,042,00043,832,000
  R&D Expenses6.8%88,637,00082,964,00077,235,00078,173,00082,306,00087,911,00065,510,00082,580,00080,414,00071,811,00098,457,00053,752,00040,188,00032,384,00026,421,00023,005,00018,225,00015,002,00012,796,00012,124,00011,435,000
EBITDA Margin26.1%-0.27-0.37-0.47-0.52-0.59-0.63-0.67-0.76-0.79-0.72-0.68-0.58---------
Interest Expenses-62.5%1,179,0003,148,0003,252,0003,177,0003,061,0002,752,0002,330,0002,150,0002,087,0002,079,0002,078,0002,075,0002,073,0004,310,0004,270,0004,038,0002,464,0002,576,0002,672,0002,721,0002,724,000
Income Taxes124.1%428,000191,000202,000-282,000160,000421,000185,000193,000179,000-30,000272,000242,000134,00035,00025,00015,00023,000-14,00044,0001,895,00074,000
Earnings Before Taxes13.7%-67,171,000-77,840,000-108,828,000-111,085,000-136,777,000-142,152,000-121,295,000-144,958,000-138,416,000-140,594,000-151,001,000-115,784,000-63,719,000-76,376,500-58,298,000-59,622,000-35,349,000-35,197,000-23,093,000-30,521,000-34,017,000
EBT Margin24.8%-0.30-0.40-0.50-0.55-0.63-0.67-0.70-0.79-0.82-0.75-0.72-0.62---------
Net Income13.4%-67,600,000-78,031,000-109,030,000-110,803,000-136,937,000-142,573,000-121,480,000-145,151,000-138,595,000-140,564,000-151,273,000-116,026,000-63,853,000-76,411,500-58,323,000-59,637,000-35,372,000-35,183,000-23,137,000-32,416,000-34,091,000
Net Income Margin24.7%-0.30-0.40-0.51-0.55-0.63-0.67-0.70-0.80-0.82-0.75-0.72-0.62---------
Free Cashflow109.9%6,686,000-67,657,000-38,656,000-87,353,000-92,488,000-92,954,000-114,457,000-118,625,000-153,162,000-107,739,000-104,197,000-79,194,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets1.8%1,4681,4421,4471,2481,3191,3941,0091,0671,1451,2361,311850894932977723559583380383261
  Current Assets0.2%1,2611,2591,2671,0661,1291,2128309029801,0931,191740791863916664497523324322208
    Cash Equivalents26.7%81464266938140346657.0091.0015985.0095.0063.0065.0049.0021077.0074.0062.0052.0030.0035.00
  Inventory5.6%43.0041.0042.0043.0041.0035.0040.0030.0025.0027.0028.0028.0024.0020.0020.0018.0014.0012.0013.0015.0014.00
  Net PPE13.1%12611110510310192.0087.0082.0078.0066.0059.0049.0040.0033.0028.0026.0027.0023.0019.0022.0023.00
Liabilities-0.3%674676662652668689647622602583552551521446441419300304296290256
  Current Liabilities-0.4%306307290277291310267252231219200198167199196176177180138127113
  Short Term Borrowings0.0%80.0080.0080.0080.0080.0080.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.00
Shareholder's Equity3.8%79476578559665170636244554265375929937248653630425927985.0093.005.00
  Retained Earnings-1.9%-2,445-2,400-2,299-2,190-2,100-1,942-1,800-1,678-1,533-1,394-1,254-1,103-987-929-852-794-734-699-663-640-699
  Additional Paid-In Capital3.0%3,2413,1463,0892,7962,7422,6652,1812,1402,0902,0502,0121,4001,3561,4111,3841,093988977748733614
Shares Outstanding2.2%12212011911411311197.0096.0096.0091.0089.0088.00---------
Float----5,260---2,570---9,330---3,510---1,550-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations146.5%27.00-58.12-29.55-78.39-80.89-81.13-102-110-137-98.74-91.06-70.56-74.88-73.30-33.13-40.98-35.1019.00-48.39-35.75-31.82
  Share Based Compensation31.8%64.0049.0058.0044.0041.0036.0040.0041.0035.0030.0026.0035.0023.0016.0015.0012.007.002.0020.0010.004.00
Cashflow From Investing460.5%13825.0081.0047.0016.0022.0067.0035.0020780.00-43160.0087.00-99.17-110-16543.00-151-71.11-10013.00
Cashflow From Financing-5.5%6.007.002369.002.004681.009.004.009.005558.005.0012.002762104.001611201163.00
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

NTRA Income Statement

2024-03-31
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues  
Total revenues$ 367,741,000$ 241,756,000
Cost and expenses  
Research and development88,637,00082,306,000
Selling, general and administrative194,278,000149,627,000
Total cost and expenses442,055,000380,057,000
Loss from operations(74,314,000)(138,301,000)
Interest expense(3,124,000)(3,061,000)
Interest and other income, net10,267,0004,585,000
Loss before income taxes(67,171,000)(136,777,000)
Income tax expense(428,000)(160,000)
Net loss(67,599,000)(136,937,000)
Unrealized gain on available-for-sale securities, net of tax893,0004,564,000
Comprehensive loss$ (66,706,000)$ (132,373,000)
Net loss per share (Note 12):  
Basic (in dollars per share)$ (0.56)$ (1.23)
Diluted (in dollars per share)$ (0.56)$ (1.23)
Weighted-average number of shares used in computing basic and diluted net loss per share:  
Basic (in shares)120,814111,767
Diluted (in shares)120,814111,767
Product  
Revenues  
Total revenues$ 364,672,000$ 237,797,000
Cost and expenses  
Cost of revenues158,833,000147,754,000
Licensing and other  
Revenues  
Total revenues3,069,0003,959,000
Cost and expenses  
Cost of revenues$ 307,000$ 370,000

NTRA Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash, cash equivalents and restricted cash$ 813,817$ 642,095
Short-term investments69,121236,882
Accounts receivable, net of allowance of $7,252 and $6,481 at March 31, 2024 and December 31, 2023, respectively288,748278,289
Inventory43,02440,759
Prepaid expenses and other current assets, net46,73460,524
Total current assets1,261,4441,258,549
Property and equipment, net125,791111,210
Operating lease right-of-use assets54,55356,537
Other assets26,41715,403
Total assets1,468,2051,441,699
Current liabilities:  
Accounts payable26,03814,998
Accrued compensation39,57745,857
Other accrued liabilities142,228149,405
Deferred revenue, current portion17,70516,612
Short-term debt financing80,40180,402
Total current liabilities305,949307,274
Long-term debt financing283,273282,945
Deferred revenue, long-term portion and other liabilities20,71219,128
Operating lease liabilities, long-term portion64,16067,025
Total liabilities674,094676,372
Commitments and contingencies (Note 8)
Stockholders' equity:  
Common stock, $0.0001 par value: 750,000 shares authorized at both March 31, 2024 and December 31, 2023; 122,234 and 119,581 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively1211
Additional paid-in capital3,241,3263,145,837
Accumulated deficit(2,445,035)(2,377,436)
Accumulated other comprehensive loss(2,192)(3,085)
Total stockholders' equity794,111765,327
Total liabilities and stockholders' equity$ 1,468,205$ 1,441,699
NTRA
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company's products also comprise Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.
 CEO
 WEBSITEnatera.com
 INDUSTRYDiagnostics & Research
 EMPLOYEES2958

Natera Inc Frequently Asked Questions


What is the ticker symbol for Natera Inc? What does NTRA stand for in stocks?

NTRA is the stock ticker symbol of Natera Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Natera Inc (NTRA)?

As of Fri May 17 2024, market cap of Natera Inc is 13.07 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NTRA stock?

You can check NTRA's fair value in chart for subscribers.

What is the fair value of NTRA stock?

You can check NTRA's fair value in chart for subscribers. The fair value of Natera Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Natera Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NTRA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Natera Inc a good stock to buy?

The fair value guage provides a quick view whether NTRA is over valued or under valued. Whether Natera Inc is cheap or expensive depends on the assumptions which impact Natera Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NTRA.

What is Natera Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, NTRA's PE ratio (Price to Earnings) is -35.76 and Price to Sales (PS) ratio is 10.81. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NTRA PE ratio will change depending on the future growth rate expectations of investors.